Spectral AI (NASDAQ: MDAI) has announced that its research partners, the RCSI Skin Injury and Trauma Research Center and RCSI Connolly Hospital, have received the Best Research Project at the 2025 Education Awards for Diabetes Foot Ulcer Project using the DeepView System. This project introduced the integration of real-time multispectral imaging and AI-driven and AI-driven analyses to improve diabetic foot ulcer assessment and treatment strategies. Part of the BusinessRiver network, which connects more than 12,000 senior experts, the Education Award recognizes excellence in third-level education across Ireland. This achievement examines the clinical value of Spectral AI’s DeepView system and generates valuable real-world data for companies to prepare for wider market commercialization.
Spectrum AI (NASDAQ: MDAI) HA ANNUNCIATO CHE I SUOI PARTNER DI RICERCA, IL RCSI Skin Scars, Trauma Research Center E L’RCSI Connolly Hospital, Hanno Vinto Il Premio Per Il Miglior Progetto Di Ricerca Agli Education utilizzando il sistema deepview. Il Progetto ha dimorphrato l’Integrazione di Imaging Multispettrale in Tempo Realisi Con Analisi Basate Sull’intelligenza Artificial Gli Education Awards, Parte Della Rete Business River Che Collega Oltre 12.000 Professionalisti Senior, Riconoscono L’Eccellenza Nell’istruzione Terziaria in Tutta L’Irlanda. I am not a fan of the stakes, but I am not a fan of the stakes, but I am not a fan of the stakes.
Spectrum AI (NASDAQ: MDAI) ANUNCIóSOSSOCIOS DEASTICACIón, El RCSI Skin Scarlet and Trauma Research Center, Y EL RCSI CONNOLLY Hospital, Ganalon EL MEJOR PROYECTO DeepView. The most recent example of the city is that it is a place where people live. Los Education Awards, Parte de la Red Businessriver Que Conecta amásde 12,000 Profesionales Senior, Reconocen la Excellencia en la da da eda irlanda. The source of the matter is deep within the scope of the world.
Spectrum AI (NASDAQ: MDAI) rcsi Skin Injury and Trauma Research Center Deepview, entitled “The Skin Injury and Trauma Research Center” BusinessRiver, 12,000 yen. Spectral ai의deepview
Spectrum AI (NASDAQ: MDAI) ANNONCé Sess Sess Partenaire de Recherche, le rcsi skin wounds, trauma research center, and more. le projet adémontrel ‘intégrationde l’ l’multippectrale en temps rel avec des Analysparotéespar l ‘afind’Améliorerl’évaluationet lesstratégiesde tartement des tratement deulcèresdu pieddiabétique。 Les Education Awards, Faisant Partie du Réseau Businessriver Qui Réunit Plus de 12 000 Professionals Senior, Lexencent L’Excellence Dans l’enseignementsupérieuren Irlande. The Celebration Site is a place where students can enjoy commercialization in the past.
Spectral AI (NASDAQ: MDAI) GAB BEKANNT, DASS SEINE FORSCHUNGSPARTNER, DAS RCSI Skin Injuries and Trauma Research Center UND DAS RCSI CONNOLLY HOSPITALDS 2025 DEN BESTEN BESTEN FORSCHUNGSPROJEKTPREIS FUR IHR DeepView-System Gewonnen Haben. The analysis of the two countries is a major factor in the analysis of the two countries, and the study of the various countries. Ganz Irland from the Die Education Awards, Teil des Business River-Netzwerks, Dasüber 12.000 Leiten de Fachkräfte Verbindet and Würdigen Exzellenzin Der Tertiären Bildung. Deeser Elforg Best Attigtden Clinician Waard Dees Deep View Systems Pon Spectrum Ai und liefert wertervolle reale daten, and the unterrestrial ai auf eine breiteremarkteinführungvorbereitet.
05/20/2025-08:00 AM
Dallas, May 20, 2025 (Globe Newswire) – Spectral AI, Inc. (NASDAQ: MDAI) (“Spectral AI” or “Company”) is a leading developer of AI-driven DeepView® systems. RCSI Connolly Hospital was awarded the best research project at the 2025 Education Awards, using the DeepView system to the Diabetic Foot Ulcer (DFUS) project.
The Education Award recognizes, encourages and celebrates excellence in third-level education across Ireland, including both state-funded and private institutions. The award is part of the BusinessRiver network and brings together over 12,000 senior experts through over 30 award programs across a wide range of industries.
“This project highlights real-time multispectral imaging and AI-driven analysis and innovative integration that guides faster and more effective assessment of diabetic foot ulcers and potential treatment strategies. When working with the DeepView System, the award celebrates outstanding interdisciplinary research efforts that bring together clinical, academic and industry expertise. “This project features the innovative use of AI and imaging for real-time wound assessment and has been awarded the best research project to showcase the cutting edge technology of the DeepView System to improve patient outcomes.”
“This award-winning research from partners at RCSI is a key milestone in examining the clinical value of the DeepView® system,” said Jeremiah Sparks, Chief Commercialization Officer of Spectral AI. “Real-world data generated in Ireland not only helps to expand the clinical evidence base of DeepView, but also helps shape the commercialization strategy. These findings are strongly erected as we prepare to bring DeepView to a wider market.”
About Spectrum AI
Spectral AI, Inc. is a Dallas-based predictive AI company focusing on medical diagnosis for faster, more accurate treatment decisions in wound care, with early uses involving burned patients. The company is working to revolutionize wound care management by using “Unknowns®Seed®” using the DeepView® system. The DeepView® system is being developed as a predictive device that provides clinicians with an objective and immediate assessment of the potential for burn healing prior to treatment or other medical intervention. With its algorithm-driven outcomes and goals to surpass current standards of care in the future, the DeepView® system is expected to provide fast and accurate treatment insights into value care by improving patient outcomes and reducing healthcare costs. For more information about the DeepView® system, visit www.spectral-ai.com.
Forward-looking statements
The specific statements made in this release are “future-looking statements” within the meaning of the “safe harbor” provisions of the US Private Securities Litigation Reform Act of 1995, including statements relating to the company’s strategy, plans, objectives, initiatives and financial outlook. When used in this press release, there is no difference between “estimation”, “prediction”, “expectation”, “prediction”, “plan”, “intention”, “believe”, “believe”, “May”, “will”, “will”, “future, “suggestion”, and negative words of these or similar expressions. These forward-looking statements do not guarantee future performance, conditions, or results and contain many known unknown risks, uncertainties, assumptions and other important factors. As such, readers are warned not to undue reliance on forward-looking statements.
Investors should carefully consider the aforementioned factors, as well as other risks and uncertainties listed in the “Risk Factors” section of our SEC filing, including the above factors and the registration statements and other documents filed by the company. These filings identify and address other significant risks and uncertainties that could cause actual events or outcomes, and are materially different from those contained in forward-looking statements.
Please contact us for information on the relationship between the media and investors.
David Kugelman
Atlanta Capital Partners LLC
(866) 692-6847 toll free – USA and Canada
(404) 281-8556 Mobile and WhatsApp
Email: dk@atlcp.com
FAQ
What awards did Spectral AI research partners win at the 2025 Education Awards?
Spectral AI research partners, RCSI SWAT Research Center and RCSI Connolly Hospital, have been awarded the Best Research Project Award for Diabetic Foot Ulcer Project using the DeepView System.
How does Spectral AI’s DeepView system work with diabetic foot ulcers?
The DeepView system combines real-time, multispectral imaging with AI-driven analysis to guide faster, more effective assessments and potential treatment strategies for diabetic foot ulcers.
What is the importance of this award for MDAI stocks?
The award validates the clinical value of Spectral AI’s DeepView system and provides real-world data that supports the company’s commercialization strategy for a wider marketplace.
Who is the Spectrum AI research partner for this award-winning project?
Research partners are the RCSI Skin Injury and Trauma (SWAT) Research Centre and RCSI Connolly Hospital in Ireland.
